FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052180632> ?p ?o ?g. }

• W2052180632 endingPage "8" @default.
• W2052180632 startingPage "8" @default.
• W2052180632 abstract "Bovine herpesvirus type 1 (BoHV-1) is the causative agent of respiratory and genital tract infections; causing a high economic loss in all continents. Use of marker vaccines in IBR eradication programs is widely accepted since it allows for protection of the animals against the disease while adding the possibility of differentiating vaccinated from infected animals. The aim of the present study was the development and evaluation of safety and efficacy of a glycoprotein E-deleted (gE-) BoHV-1 marker vaccine strain (BoHV-1ΔgEβgal) generated by homologous recombination, replacing the viral gE gene with the β-galactosidase (βgal) gene. In vitro growth kinetics of the BoHV-1ΔgEβgal virus was similar to BoHV-1 LA. The immune response triggered by the new recombinant strain in cattle was characterized both as live attenuated vaccine (LAV) and as an inactivated vaccine. BoHV-1ΔgEβgal was highly immunogenic in both formulations, inducing specific humoral and cellular immune responses. Antibody titers found in animals vaccinated with the inactivated vaccine based on BoHV-1ΔgEβgal was similar to the titers found for the control vaccine (BoHV-1 LA). In the same way, titers of inactivated vaccine groups were significantly higher than any of the LAV immunized groups, independently of the inoculation route (p < 0.001). Levels of IFN-γ were significantly higher (p < 0.001) in those animals that received the LAV compared to those that received the inactivated vaccine. BoHV-1ΔgEβgal exhibited an evident attenuation when administered as a LAV; no virus was detected in nasal secretions of vaccinated or sentinel animals during the post-vaccination period. BoHV-1ΔgEβgal, when used in either formulation, elicited an efficient immune response that protected animals against challenge with virulent wild-type BoHV-1. Also, the deletion of the gE gene served as an immunological marker to differentiate vaccinated animals from infected animals. All animals vaccinated with the BoHV-1ΔgE βgal strain were protected against disease after challenge and shed significantly less virus than control calves, regardless of the route and formulation they were inoculated. Based on its attenuation, immunogenicity and protective effect after challenge, BoHV-1ΔgEβgal virus is an efficient and safe vaccine candidate when used either as inactivated or as live attenuated forms." @default.
• W2052180632 created "2016-06-24" @default.
• W2052180632 creator A5000552332 @default.
• W2052180632 creator A5010113064 @default.
• W2052180632 creator A5020458458 @default.
• W2052180632 creator A5022723078 @default.
• W2052180632 creator A5025057768 @default.
• W2052180632 creator A5044095482 @default.
• W2052180632 creator A5044486376 @default.
• W2052180632 creator A5044503671 @default.
• W2052180632 creator A5051936910 @default.
• W2052180632 creator A5062571711 @default.
• W2052180632 date "2014-01-01" @default.
• W2052180632 modified "2023-10-18" @default.
• W2052180632 title "Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle" @default.
• W2052180632 cites W1963508015 @default.
• W2052180632 cites W1977204241 @default.
• W2052180632 cites W2004368958 @default.
• W2052180632 cites W2018838535 @default.
• W2052180632 cites W2026213587 @default.
• W2052180632 cites W2028333501 @default.
• W2052180632 cites W2034812097 @default.
• W2052180632 cites W2049359252 @default.
• W2052180632 cites W2063450941 @default.
• W2052180632 cites W2064719394 @default.
• W2052180632 cites W2067941340 @default.
• W2052180632 cites W2069293410 @default.
• W2052180632 cites W2073970359 @default.
• W2052180632 cites W2077653019 @default.
• W2052180632 cites W2118600936 @default.
• W2052180632 cites W2145868614 @default.
• W2052180632 doi "https://doi.org/10.1186/1746-6148-10-8" @default.
• W2052180632 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3896737" @default.
• W2052180632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24401205" @default.
• W2052180632 hasPublicationYear "2014" @default.
• W2052180632 type Work @default.
• W2052180632 sameAs 2052180632 @default.
• W2052180632 citedByCount "25" @default.
• W2052180632 countsByYear W20521806322014 @default.
• W2052180632 countsByYear W20521806322015 @default.
• W2052180632 countsByYear W20521806322016 @default.
• W2052180632 countsByYear W20521806322017 @default.
• W2052180632 countsByYear W20521806322018 @default.
• W2052180632 countsByYear W20521806322019 @default.
• W2052180632 countsByYear W20521806322020 @default.
• W2052180632 countsByYear W20521806322021 @default.
• W2052180632 countsByYear W20521806322022 @default.
• W2052180632 countsByYear W20521806322023 @default.
• W2052180632 crossrefType "journal-article" @default.
• W2052180632 hasAuthorship W2052180632A5000552332 @default.
• W2052180632 hasAuthorship W2052180632A5010113064 @default.
• W2052180632 hasAuthorship W2052180632A5020458458 @default.
• W2052180632 hasAuthorship W2052180632A5022723078 @default.
• W2052180632 hasAuthorship W2052180632A5025057768 @default.
• W2052180632 hasAuthorship W2052180632A5044095482 @default.
• W2052180632 hasAuthorship W2052180632A5044486376 @default.
• W2052180632 hasAuthorship W2052180632A5044503671 @default.
• W2052180632 hasAuthorship W2052180632A5051936910 @default.
• W2052180632 hasAuthorship W2052180632A5062571711 @default.
• W2052180632 hasBestOaLocation W20521806321 @default.
• W2052180632 hasConcept C104317684 @default.
• W2052180632 hasConcept C105702510 @default.
• W2052180632 hasConcept C108625454 @default.
• W2052180632 hasConcept C153911025 @default.
• W2052180632 hasConcept C159047783 @default.
• W2052180632 hasConcept C159654299 @default.
• W2052180632 hasConcept C203014093 @default.
• W2052180632 hasConcept C22070199 @default.
• W2052180632 hasConcept C2522874641 @default.
• W2052180632 hasConcept C2776409557 @default.
• W2052180632 hasConcept C2776872762 @default.
• W2052180632 hasConcept C2777594917 @default.
• W2052180632 hasConcept C2778022156 @default.
• W2052180632 hasConcept C2780727368 @default.
• W2052180632 hasConcept C2780801004 @default.
• W2052180632 hasConcept C32611913 @default.
• W2052180632 hasConcept C40767141 @default.
• W2052180632 hasConcept C54602769 @default.
• W2052180632 hasConcept C55493867 @default.
• W2052180632 hasConcept C60987743 @default.
• W2052180632 hasConcept C86803240 @default.
• W2052180632 hasConcept C8891405 @default.
• W2052180632 hasConcept C89423630 @default.
• W2052180632 hasConceptScore W2052180632C104317684 @default.
• W2052180632 hasConceptScore W2052180632C105702510 @default.
• W2052180632 hasConceptScore W2052180632C108625454 @default.
• W2052180632 hasConceptScore W2052180632C153911025 @default.
• W2052180632 hasConceptScore W2052180632C159047783 @default.
• W2052180632 hasConceptScore W2052180632C159654299 @default.
• W2052180632 hasConceptScore W2052180632C203014093 @default.
• W2052180632 hasConceptScore W2052180632C22070199 @default.
• W2052180632 hasConceptScore W2052180632C2522874641 @default.
• W2052180632 hasConceptScore W2052180632C2776409557 @default.
• W2052180632 hasConceptScore W2052180632C2776872762 @default.
• W2052180632 hasConceptScore W2052180632C2777594917 @default.
• W2052180632 hasConceptScore W2052180632C2778022156 @default.
• W2052180632 hasConceptScore W2052180632C2780727368 @default.
• W2052180632 hasConceptScore W2052180632C2780801004 @default.

• next